Biotech Week in Review: Cross Border China Pharma Activity
Aggregated Source: China Stocks News and Analysis from Seeking Alpha
December 2, 2007|
The interaction in biopharma activity between China and the West was a
major theme last week, as evidenced in part by Pfizer (PFE),
which said it expects to increase its investment in Asia, according to
Martin Mackay, Pfizer’s president of global research and development.
Original URL: Click here to visit original article
Copyright China Stocks News and Analysis from Seeking Alpha
Print This Post
|
Email This Page